4-amino-n-(2,6-dimethylphenyl)phthalimide has been researched along with riluzole in 1 studies
| Studies (4-amino-n-(2,6-dimethylphenyl)phthalimide) | Trials (4-amino-n-(2,6-dimethylphenyl)phthalimide) | Recent Studies (post-2010) (4-amino-n-(2,6-dimethylphenyl)phthalimide) | Studies (riluzole) | Trials (riluzole) | Recent Studies (post-2010) (riluzole) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 1,244 | 153 | 572 |
| Protein | Taxonomy | 4-amino-n-(2,6-dimethylphenyl)phthalimide (IC50) | riluzole (IC50) |
|---|---|---|---|
| Sodium channel protein type 2 subunit alpha | Rattus norvegicus (Norway rat) | 4.73 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 10 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 1.733 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 1.733 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anger, T; Madge, DJ; Mulla, M; Riddall, D | 1 |
1 review(s) available for 4-amino-n-(2,6-dimethylphenyl)phthalimide and riluzole
| Article | Year |
|---|---|
Medicinal chemistry of neuronal voltage-gated sodium channel blockers.
Topics: Amyotrophic Lateral Sclerosis; Analgesics; Anticonvulsants; Epilepsy; Humans; Ion Channel Gating; Models, Molecular; Mutation; Nerve Tissue Proteins; Neuroprotective Agents; Protein Binding; Sodium Channel Blockers; Sodium Channels; Stroke | 2001 |